MICROVISION, INC. 8-K

What Happened

• MicroVision, Inc. filed a Form 8‑K on June 12, 2026 announcing Amendment No. 1 to its At‑The‑Market (ATM) Issuance Sales Agreement with Deutsche Bank Securities, Mizuho Securities USA and Craig‑Hallum Capital Group. The amendment references a new Form S‑3 registration statement filed the same day and updates the original sales agreement; about $42,000,000 of common stock remains available for sale under the ATM program.
• The company also submitted an application to transfer its common stock listing from The Nasdaq Global Market to The Nasdaq Capital Market after previously receiving notice that it failed to meet Nasdaq’s $1.00 minimum bid price requirement. MicroVision issued a press release announcing a business update and interactive Q&A session for shareholders.

Key Details

• Amendment No. 1 to the ATM sales agreement was entered on June 12, 2026 and becomes effective as of the effective date of the new Form S‑3 registration statement filed that day.
• Approximately $42,000,000 of common stock remains unsold and available for issuance under the ATM program.
• The company applied to transfer its listing to The Nasdaq Capital Market; if approved, Nasdaq may grant an additional 180‑calendar‑day compliance period during which the stock must close at $1.00+ for 10 consecutive business days to regain compliance (subject to Nasdaq discretion).
• A press release dated June 12, 2026 (filed as Exhibit 99.1) announces a business update and interactive Q&A about the 2026 Annual Meeting of Shareholders.

Why It Matters

• The ATM amendment and new S‑3 registration keep MicroVision’s ability to raise capital through its at‑the‑market program, with roughly $42M still available—useful for funding operations or strategic initiatives without a traditional offering.
• The Nasdaq transfer application is a procedural step tied to the company’s failure to meet the $1.00 minimum bid requirement; approval could provide extra time to restore compliance, but there is no guarantee. Trading is expected to continue under the ticker MVIS while the transfer is reviewed.